It has been evidenced that melanoma cell lines with high levels of MITF (MITFhigh) were sensitive to either BRAFV600E or MEK inhibition, whereas cells with low MITF levels (MITFlow) displayed intrinsic resistance against the same drugs (112). Here, MITF is linked to melanoma.